+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Intelligence in Diabetes Management Market Research Report by Device, technique, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4904643
  • Report
  • April 2022
  • Region: Global
  • 198 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Crayon Group
  • Eyenuk, Inc.
  • IBM Corporation
  • Nasdaq Inc
  • Sanofi SA
The Global Artificial Intelligence in Diabetes Management Market size was estimated at USD 452.69 million in 2021, USD 590.45 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 30.60% to reach USD 2,247.24 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Artificial Intelligence in Diabetes Management to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Device, the market was studied across Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices.
  • Based on technique, the market was studied across Case-based Reasoning and Intelligent Data Analysis.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Artificial Intelligence in Diabetes Management market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Diabetes Management Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Diabetes Management Market, including Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd, HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc, Novartis AG, Novo Nordisk A/S, Sanofi SA, Virta Health Corp., Vodafone Group PLC, Whisk, and xbird GmbH.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Artificial Intelligence in Diabetes Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Diabetes Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Diabetes Management Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Diabetes Management Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Diabetes Management Market?
6. What is the market share of the leading vendors in the Global Artificial Intelligence in Diabetes Management Market?
7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence in Diabetes Management Market?
Frequently Asked Questions about the Global Artificial Intelligence in Diabetes Management Market

What is the estimated value of the Global Artificial Intelligence in Diabetes Management Market?

The Global Artificial Intelligence in Diabetes Management Market was estimated to be valued at $452.7 Million in 2021.

What is the growth rate of the Global Artificial Intelligence in Diabetes Management Market?

The growth rate of the Global Artificial Intelligence in Diabetes Management Market is 30.6%, with an estimated value of $2247.2 Million by 2027.

What is the forecasted size of the Global Artificial Intelligence in Diabetes Management Market?

The Global Artificial Intelligence in Diabetes Management Market is estimated to be worth $2247.2 Million by 2027.

Who are the key companies in the Global Artificial Intelligence in Diabetes Management Market?

Key companies in the Global Artificial Intelligence in Diabetes Management Market include Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann and HCL Technologies Limited.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Crayon Group
  • Eyenuk, Inc.
  • IBM Corporation
  • Nasdaq Inc
  • Sanofi SA

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for smart glucose monitoring device
5.1.1.2. Rising geriatric population and unhealthy lifestyle
5.1.1.3. Large number of type 2 diabetes patients
5.1.2. Restraints
5.1.2.1. Expensive AI-based medical devices
5.1.3. Opportunities
5.1.3.1. Increasing mobile apps to monitor and manage diabetes
5.1.3.2. Inclination towards the home care or self-management of diabetes
5.1.4. Challenges
5.1.4.1. Lack of awareness among the people
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Artificial Intelligence in Diabetes Management Market, by Device
6.1. Introduction
6.2. Diagnostic Devices
6.3. Glucose Monitoring Devices
6.4. Insulin Delivery Devices
7. Artificial Intelligence in Diabetes Management Market, by technique
7.1. Introduction
7.2. Case-based Reasoning
7.3. Intelligent Data Analysis
8. Americas Artificial Intelligence in Diabetes Management Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Artificial Intelligence in Diabetes Management Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Artificial Intelligence in Diabetes Management Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Bigfoot Biomedical, Inc.
12.3. Cardinal Health Inc.
12.4. Crayon Group
12.5. Diabnext
12.6. DreaMed Diabetes, Ltd.
12.7. Eyenuk, Inc.
12.8. F. Hoffmann-La Roche Ltd
12.9. HCL Technologies Limited
12.10. IBM Corporation
12.11. Karger AG
12.12. Medtronic PLC
12.13. Nasdaq Inc
12.14. Novartis AG
12.15. Novo Nordisk A/S
12.16. Sanofi SA
12.17. Virta Health Corp.
12.18. Vodafone Group PLC
12.19. Whisk
12.20. xbird GmbH
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: DYNAMICS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2027
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2027
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 19. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 20. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 21. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 22. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. SINGAPORE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. TAIWAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 39. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. SINGAPORE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. TAIWAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: SCORES
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: BUSINESS STRATEGY
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: PRODUCT SATISFACTION
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RANKING
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MERGER & ACQUISITION
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: INVESTMENT & FUNDING
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Bigfoot Biomedical, Inc.
  • Cardinal Health Inc.
  • Crayon Group
  • Diabnext
  • DreaMed Diabetes, Ltd.
  • Eyenuk, Inc.
  • F. Hoffmann-La Roche Ltd
  • HCL Technologies Limited
  • IBM Corporation
  • Karger AG
  • Medtronic PLC
  • Nasdaq Inc
  • Novartis AG
  • Novo Nordisk A/S
  • Sanofi SA
  • Virta Health Corp.
  • Vodafone Group PLC
  • Whisk
  • xbird GmbH
Note: Product cover images may vary from those shown

Loading
LOADING...